Zhengnan Yang, Jingtian Zhou, Fan Fei, Bohao Zheng, Sophie Xin Yang, Thomas M Pearce, Peidong Zhang, Liang Huang, Jing Yue, Qiuhong Shen, Yiwei Du, Xiaoling Liao, Siyu Cheng, Li Li, Jian Liang, Luyao Liu, Xiaoxiao Wan, Michael D Taylor, Joseph R Ecker, Shengtao Zhou, Jeremy N Rich, Linjie Zhao
{"title":"Macrophage-mediated brain-bone marrow crosstalk promotes chronic stress-induced glioma growth.","authors":"Zhengnan Yang, Jingtian Zhou, Fan Fei, Bohao Zheng, Sophie Xin Yang, Thomas M Pearce, Peidong Zhang, Liang Huang, Jing Yue, Qiuhong Shen, Yiwei Du, Xiaoling Liao, Siyu Cheng, Li Li, Jian Liang, Luyao Liu, Xiaoxiao Wan, Michael D Taylor, Joseph R Ecker, Shengtao Zhou, Jeremy N Rich, Linjie Zhao","doi":"10.1016/j.ccell.2026.05.018","DOIUrl":null,"url":null,"abstract":"<p><p>Stress is associated with increased cancer morbidity and mortality. Here, we show that chronic stress accelerates glioma growth and reduces survival of tumor-bearing mice. Integrated multi-omics analysis of syngeneic glioma samples reveals stress-induced CD45<sup>+</sup>CD11b<sup>+</sup>C5aR1<sup>+</sup> macrophages, termed stress-associated macrophages (SAMs). Using parabiosis experiments in mice, we demonstrate that SAMs are derived from bone marrow monocytes. Stress-activated sympathetic nerve promotes the differentiation of ADRB2<sup>+</sup> bone marrow monocytes into SAMs, which can be antagonized by selective ablation of catecholaminergic nerves. Conditional knockout of C5ar1 in macrophages, or pharmacologic C5aR inhibition, reduces SAMs and attenuates stress-induced glioma tumor growth in vivo. SAMs exhibit elevated CD36 expression, leading to excessive intracellular lipid accumulation and peroxidization, dampening their phagocytotic capacity. SAMs abundance correlates with self-reported stress levels and portended prognosis in glioma patients. Collectively, these findings suggest that stress reprograms tumor immune microenvironment by inducing molecularly distinguished monocyte-derived macrophages, revealing potential opportunities for immune-based cancer therapies.</p>","PeriodicalId":9670,"journal":{"name":"Cancer Cell","volume":" ","pages":"1587-1604.e7"},"PeriodicalIF":56.1000,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Cell","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ccell.2026.05.018","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Stress is associated with increased cancer morbidity and mortality. Here, we show that chronic stress accelerates glioma growth and reduces survival of tumor-bearing mice. Integrated multi-omics analysis of syngeneic glioma samples reveals stress-induced CD45+CD11b+C5aR1+ macrophages, termed stress-associated macrophages (SAMs). Using parabiosis experiments in mice, we demonstrate that SAMs are derived from bone marrow monocytes. Stress-activated sympathetic nerve promotes the differentiation of ADRB2+ bone marrow monocytes into SAMs, which can be antagonized by selective ablation of catecholaminergic nerves. Conditional knockout of C5ar1 in macrophages, or pharmacologic C5aR inhibition, reduces SAMs and attenuates stress-induced glioma tumor growth in vivo. SAMs exhibit elevated CD36 expression, leading to excessive intracellular lipid accumulation and peroxidization, dampening their phagocytotic capacity. SAMs abundance correlates with self-reported stress levels and portended prognosis in glioma patients. Collectively, these findings suggest that stress reprograms tumor immune microenvironment by inducing molecularly distinguished monocyte-derived macrophages, revealing potential opportunities for immune-based cancer therapies.
期刊介绍:
Cancer Cell is a journal that focuses on promoting major advances in cancer research and oncology. The primary criteria for considering manuscripts are as follows:
Major advances: Manuscripts should provide significant advancements in answering important questions related to naturally occurring cancers.
Translational research: The journal welcomes translational research, which involves the application of basic scientific findings to human health and clinical practice.
Clinical investigations: Cancer Cell is interested in publishing clinical investigations that contribute to establishing new paradigms in the treatment, diagnosis, or prevention of cancers.
Insights into cancer biology: The journal values clinical investigations that provide important insights into cancer biology beyond what has been revealed by preclinical studies.
Mechanism-based proof-of-principle studies: Cancer Cell encourages the publication of mechanism-based proof-of-principle clinical studies, which demonstrate the feasibility of a specific therapeutic approach or diagnostic test.